VEGF-mediated survivin expression in neuroblastoma cells

被引:56
作者
Beierle, EA
Nagaram, A
Dai, W
Iyengar, M
Chen, MK
机构
[1] Univ Florida, Dept Surg, JHMHSC, Gainesville, FL 32610 USA
[2] Univ Med & Dent New Jersey, Dept Surg, Newark, NJ 07103 USA
关键词
neuroblastoma; IMR-32; survivin; VEGF; Akt; LY294002; pediatric tumors;
D O I
10.1016/j.jss.2005.03.009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Vascular endothelial growth factor (VEGF) up-regulates a number of cellular survival signals in endothelial cells. We hypothesize that VEGF will up-regulate survivin, a member of the IAP family of anti-apoptotic proteins, via the PI3K/Akt cell signaling pathway in human neuroblastoma cells. Materials and methods. IMR-32 human neuroblastoma cells are cultured with VEGF at varying times and in escalating doses. A specific inhibitor of PI3-kinase, LY294002, is used to block Akt phosphorylation. Immunoblot is used to measure protein expression, and Hoechst staining is used to detect apoptosis. Results. Stimulation of IMR-32 neuroblastoma cells with VEGF results in an increase in survivin protein expression in both a dose- and a time-dependent fashion. Akt phosphorylation is also increased after stimulation with exogenous VEGF. Blockade of Akt phosphorylation with LY294002 abrogates the effects of VEGF upon survivin and phosphorylated Akt protein expression. Conclusions. VEGF has been shown to up-regulate a number of survival signals in endothelial cells. We have found that exposure of human neuroblastoma cells to exogenous VEGF results in an increased expression of survivin protein and phosphorylated Akt, and inhibition of PI3-kinase abrogates those effects. It appears that VEGF is important for promotion of neuroblastoma cellular survival through the up-regulation of survival proteins, and not only through its angiogenic properties. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 53 条
  • [1] A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
    Ambrosini, G
    Adida, C
    Altieri, DC
    [J]. NATURE MEDICINE, 1997, 3 (08) : 917 - 921
  • [2] Angelov L, 1999, CANCER RES, V59, P5536
  • [3] The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma
    Azuhata, T
    Scott, D
    Takamizawa, S
    Wen, J
    Davidoff, A
    Fukuzawa, M
    Sandler, A
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2001, 36 (12) : 1785 - 1791
  • [4] Differential expression of Bcl-2 and Bax may enhance neuroblastoma survival
    Beierle, EA
    Dai, W
    Iyengar, R
    Langham, MR
    Copeland, EM
    Chen, MK
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2003, 38 (03) : 486 - 491
  • [5] VEGF upregulates BCL-2 expression and is associated with decreased apoptosis in neuroblastoma cells
    Beierle, EA
    Strande, LF
    Chen, MK
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2002, 37 (03) : 467 - 471
  • [6] Characterization of the cell death process induced by staurosporine in human neuroblastoma cell lines
    Boix, J
    Llecha, N
    Yuste, VJ
    Comella, JX
    [J]. NEUROPHARMACOLOGY, 1997, 36 (06) : 811 - 821
  • [7] MICROVESSEL QUANTITATION AND PROGNOSIS IN INVASIVE BREAST-CARCINOMA
    BOSARI, S
    LEE, AKC
    DELELLIS, RA
    WILEY, BD
    HEATLEY, GJ
    SILVERMAN, ML
    [J]. HUMAN PATHOLOGY, 1992, 23 (07) : 755 - 761
  • [8] EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN BREAST-CANCER
    BROWN, LF
    BERSE, B
    JACKMAN, RW
    TOGNAZZI, K
    GUIDI, AJ
    DVORAK, HF
    SENGER, DR
    CONNOLLY, JL
    SCHNITT, SJ
    [J]. HUMAN PATHOLOGY, 1995, 26 (01) : 86 - 91
  • [9] BROWN LF, 1993, CANCER RES, V53, P4727
  • [10] PI3-K/AKT regulation of NF-κB signaling events in suppression of TNF-induced apoptosis
    Burow, ME
    Weldon, CB
    Melnik, LI
    Duong, BN
    Collins-Burow, BM
    Beckman, BS
    McLachlan, JA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (02) : 342 - 345